Your search history is turned on.
Date: May 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
BHC Q1 2024 Form 10-Q-2024-05-02-16-58 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Fo...
Exhibit 31.2 Q1 2024 Exhibit 31.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, John S. Barresi, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Bausch Health Companies Inc. (the Company); 2. Based on my knowledge, this report does not...
Exhibit 31.1 Q1 2024 Exhibit 31.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Thomas J. Appio, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Bausch Health Companies Inc. (the Company); 2. Based on my knowledge, this report does not...
Bausch Health Companies Inc. Q1 2024 Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations INTRODUCTION Unless the context otherwise indicates, as used in this Managements Discussion and Analysis of Financial Condition and Results of Operations, the terms we, us, our, the Company, Bausch Health, and similar term...
Ex99.1-Q1-2024 Investor Contact: Media Contact: Garen Sarafian Kevin Wiggins [email protected] [email protected] (877) 281-6642 (toll free) (908) 541-3785 BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2024 RESULTS First quarter revenues of $2.15 billion, up 11% on a Reported and 8% on an Organic1 basis Year-over-year revenue growth in all s...
Date: April 11, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Investor Contact: Media Contact: Garen Sarafian Kevin Wiggins [email protected] [email protected] (877) 281-6642 (toll free) (848) 541-3785 Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwichs Abbreviated New Drug Application Until 202...
Date: April 5, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Ex99.1-Q4-2023 Investor Contacts: Media Contact: Solebury Strategic Communications Kevin Wiggins [email protected] [email protected] (877) 281-6642 (toll free) (908) 541-3785 Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals LAVAL, QC, April 5, 2024 Bausch Health Companies Inc. (NY...
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - BHC - Certificate of Abridgement (NI 54-101)(CAN_DMS_1004247128.1).docx ABRIDGEMENT CERTIFICATE PURSUANT TO SECTION 2.20 OF NATIONAL INSTRUMENT 54-101 COMMUNICATION WITH BENEFICIAL OWNERS OF SECURITIES OF A REPORTING ISSUER I, Seana Carson, General Counsel of Bausch Health Companies Inc. (the Company), hereby certify for and on behalf of...
2023 Annual Report 2150 St. Elzar Blvd. West Laval, Quebec H7L 4A8 Canada (800) 361-1448 www.bauschhealth.com Dear Shareholders, When I wrote to you last year, I stated that our leadership team was laser-focused on driving sales and EBITDA growth, developing a high-performance, results-oriented culture, keenly focused on operating rigor behind R&D and b...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by R...